Funding for this research was provided by:
1022 Talent Training Program of Zhejiang Cancer Hospital
Received: 23 October 2017
Accepted: 21 February 2018
First Online: 5 March 2018
Ethics approval and consent to participate
: This study was approved by the Medical Ethics Committee of Zhejiang Cancer Hospital. All included subjects have provided written informed consent.
: Not applicable.
: Yang W. Shao, Xiaoling Tong and Xue Wu are the shareholders or employees of Geneseeq Technology Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.